Beijing Tongrentang Co., Ltd (SHA:600085)

Market Cap	48.25B
Revenue (ttm)	18.60B
Net Income (ttm)	1.45B
Shares Out	1.37B
EPS (ttm)	1.06
PE Ratio	33.25
Forward PE	33.35
Dividend	0.50 (1.42%)
Ex-Dividend Date	Jun 30, 2025

Volume	9,550,300
Average Volume	16,029,970
Open	35.35
Previous Close	35.37
Day's Range	35.10 - 35.39
52-Week Range	30.84 - 46.27
Beta	0.20
RSI	39.68
Earnings Date	Aug 30, 2025

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally. The company offers various product dosage forms, such as pills, dripping pills, powders, capsules, oral liquids, and tonics, as well as alcoholic preparations. It also engages in medicine plantation; aquaculture; investment management; and other related services. The company exports its products. Its products are used for cardiovascular, gynecology, heat clearing class, respiratory system, nourishing...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 17,883
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2024, Beijing Tongrentang's revenue was 18.60 billion, an increase of 4.12% compared to the previous year's 17.86 billion. Earnings were 1.53 billion, a decrease of -8.54%.